Current Status of Treatment of Spinal and Bulbar Muscular Atrophy

Tsai, L. K. (2012). Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets. Neural Plasticity, 2012(), 524-536. https://doi.org/10.1155/2012/456478
曾永輝（1998）。Recent Advances in Spinal Surgery。台灣醫學，2(2)，199-203。https://doi.org/10.6320/FJM.1998.2(2).12
陳致宇、許建文、廖翊廷、吳凱文、張至宏、楊榮森（2010）。Diagnosis and Treatment of Spinal Metastatsis。台灣醫學，14(2)，222-231。https://doi.org/10.6320/FJM.2010.14(2).14
陳郁佳（2009）。Drug Screening for Spinal Muscular Atrophy and Investigation of the Mechanism of Drug Effect〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-0306200915085300
Fan, H. C., Chang, Y. K., Show, B. C., Chen, Y. Y., Wang, L. T., Yang, H. C., & Chi, C. S. (2021). Clinical Characteristics of Spinal Muscular Atrophy. 童綜合醫學雜誌, 15(S), 47-54. https://doi.org/10.3966/20713592202109150S007